CpG ODN quickly activates T and B lymphocytes, promote the production of Th1-type pro-inflammatory cytokines, and directly acts on DCs through the TLR9 signaling pathway to induce the maturation/activation of DCs, which has a broad application prospect in anti-tumor therapy (44). The gene discussed is TLR9; the disease is neoplasm.